RAB15 interacts with FGFR1 involved in the recycling of glioma cell receptors and can be used as a pharmacological target to inhibit or down-regulate the proliferation of tumors by stimulating degradation (Giulietti et al., 2017). This evidence concerns the gene RAB15 and central nervous system cancer.